The Quest for the Best Long Term Care

The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy.
Food and Drug Administration–Press Releases

Related posts:

1. FDA Press Releases: FDA approves Incivek for hepatitis C The U.S. Food and Drug Administration today approved Incivek (telaprevir)...
2. FDA Press Releases: FDA approves Ferriprox to treat patients with excess iron in the body The U.S. Food and Drug Administration today approved Ferriprox (deferiprone)...
3. FDA Press Releases: FDA approves first DNA test to help manage CMV infection in organ transplant patients The U.S. Food and Drug Administration today approved the first...
4. FDA Press Releases: FDA approves injectable gel to treat fecal incontinence The U.S. Food and Drug Administration today approved a sterile,...
5. FDA Press Releases: FDA approves genetic test to help some colon cancer patients, physicians considering Erbitux therapy The U.S. Food and Drug Administration today approved the first...